• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2426-0500
Device Problems Material Separation (1562); Separation Failure (2547)
Patient Problems No Consequences Or Impact To Patient (2199); No Patient Involvement (2645)
Event Date 11/29/2019
Event Type  malfunction  
Manufacturer Narrative
No product will be returned per customer.The customer declined to return the product for failure investigation.The root cause of this failure was not identified.
 
Event Description
It was reported that the event occurred at the cardiac cath lab.The iv pump tubing pulled apart at the top of the flexible part of the tubing, above the cassette.Normal saline was running at the time.It was reported that no patient care was delayed and it did not contribute to, or result in serious adverse impact to patient.
 
Event Description
It was reported from the cardiac cath lab that the tubing set separated from the upper fitment during a normal saline infusion.It was further confirmed during follow up, that there was no patient involvement associated with this event, and subsequently, no patient harm or impact as a result of this event.
 
Manufacturer Narrative
The customer¿s report that the tubing set separated was confirmed.The set was visually inspected for kinks, incomplete bonding engagements, holes/tears in the tubing or damages to the components.Visual inspection of the set noted separation from the inlet port of the distal smartsite below the lower fitment.No separations to the upper fitment were observed.No other abnormalities were observed.Examination under magnification noted that both sides of the tubing had insufficient solvent applied at the engagement.A gap was also observed, indicating that the expected tubing was not fully inserted.Further handling/tug of the rest of the set's tubing engagements observed no separation or any issues.Functional testing was deemed unnecessary due to the separated tubing and the leaking that would occur.Dimensional analysis of the tubing's outer diameter observed to be within specification(s).The root cause of the separation is due to a combination of factors related to insufficient solvent and improper assembly due to equipment and/or operator error.
 
Event Description
It was reported after two hours of normal saline infusion, the tubing set separated from the upper fitment.The event occurred in the cardiac cath lab.There was no consequences or impact to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key9513451
MDR Text Key191110343
Report Number9616066-2019-03736
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 12/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/14/2022
Device Model Number2426-0500
Device Catalogue Number2426-0500
Device Lot Number19113097
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/26/2020
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/23/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received04/03/2020
04/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
8100,8015, THERAPY DATE (B)(6) 2019
Patient Age69 YR
-
-